Gel tested as potential Non-Surgical option for face skin cancer precursor
NCT ID NCT02723721
Summary
This study tested whether a topical gel called Picato could treat lentigo maligna, a pre-cancerous skin condition on the face that can turn into melanoma. It was for patients who were not eligible for or refused standard surgery. Researchers applied the gel for three days to see if it could completely clear the lesion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LENTIGO MALIGNA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HP Hopital Avicenne
Bobigny, 93000, France
-
AP-HP Hôpital Ambroise Paré
Boulogne-Billancourt, France
-
CHRU de Lille
Lille, France
-
CHU de Nantes
Nantes, France
-
CHU de Nice
Nice, 06000, France
-
CHU de Saint Etienne
Saint-Etienne, France
-
Hôpital Pontchaillou
Rennes, France
-
Hôpital du Morvan
Brest, France
Conditions
Explore the condition pages connected to this study.